维普中文期刊产品整合服务
10篇 您的检索式:作者名="Botwood"
    题名 作者 年代 出处 被引量
1The risks of treating keloids with radiotherapy显示文摘Botwood N Lewanski C Lowdell C 1999Br J Radiol1999,72,864:1
2The risks of treating kelcids with radiotherapy显示文摘BOTWOOD N LEWANSKI C LOWDELL C 1999Br J Radid1999,72,:1
3The risks of treating keloids with radiotherapy显示文摘Botwood N Lewanski C Lowdell C 1999Br J Radiol1999,72,:1
4Raltitrexed plus radiotherapy for the treatment of unresectable/recurrent rectal cancer:aphase I study显示文摘James RD Botwood N Vernon CC 2003AnnOncol2003,14,4:1
5Gefitinib (IRESSA) in Patients of Asian Origin with Refractory Advanced Non-small Cell Lung Cancer: Subset Analysis from the ISEL Study显示文摘Alex Chang Purvish Parikh Sumitra Thongprasert Eng Huat Tan Reury-Perng Perng Domingo Ganzon Chih-Hsin Yang Chao-Jung Tsao Claire Watkins Nick Botwood Nick Thatcher 2006Journal of Thoracic Oncology2006,,8:1
6The risks of treating keloids with radiotherapy 显示文摘Botwood N Lewanski C Lowdell C 1999Br J Radiol1999,72,864:1
7Phase Ⅲ trial of FOLFOX plus bevacizumab or cediranib (AZD2171) as first-line treatment of patients with metastatic colorectal cancer: HORIZON Ⅲ 显示文摘Robertson J D Botwood N A Rothenberg M L 2009ClinColorectalCancer2009,8,1:1
8Gefitinib (IRESSA) in Patients of Asian Origin with Refractory Advanced Non-small Cell Lung Cancer: Subset Analysis from the ISEL Study显示文摘Alex Chang Purvish Parikh Sumitra Thongprasert Eng Huat Tan Reury-Perng Perng Domingo Ganzon Chih-Hsin Yang Chao-Jung Tsao Claire Watkins Nick Botwood Nick Thatcher 2006Journal of Thoracic Oncology2006,,8:1
9Phase III trial of FOLFOX plus bevaeizumab or cediranib( AZD2171 ) as first-line treatment of patients with metastatic colorectal cancer: HORIZON III 显示文摘Robertson JD Botwood NA Rothenberg ML 2009Clin Colorectal Cancer2009,8,1:1
10The risks of treating keloids with radiotherapy 显示文摘Botwood N Lewanski C I-xJwdell C 1999Br J Radiol1999,72,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费